nimbolide has been researched along with Benign Neoplasms, Brain in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, J; Chhipa, RR; Clark, JP; Dasgupta, B; Gasilina, A; Ghosh, J; Ghosh, PK; Henry, H; Karkare, S; Kumar, A; Liu, X; Nassar, N; Pauletti, GM | 1 |
1 other study(ies) available for nimbolide and Benign Neoplasms, Brain
Article | Year |
---|---|
Direct inhibition of retinoblastoma phosphorylation by nimbolide causes cell-cycle arrest and suppresses glioblastoma growth.
Topics: Animals; Antineoplastic Agents, Phytogenic; Azadirachta; Brain Neoplasms; Cell Line, Tumor; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; ErbB Receptors; G1 Phase Cell Cycle Checkpoints; Glioblastoma; Humans; Limonins; Male; Mice; Mice, Nude; Phosphorylation; Plant Extracts; Plant Leaves; Protein Processing, Post-Translational; Retinoblastoma Protein; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |